title: Serum free light chain reduction correlates with response and progression-free survival following carfilzomib therapy in relapsed/refractory multiple myeloma.
authors.affiliation: a Washington University School of Medicine , St. Louis , MO , USA.
authors.forename: Ravi
authors.initials: R
authors.lastname: Vij
authors.affiliation: b M. D. Anderson Cancer Center , Houston , TX , USA.
authors.forename: Michael
authors.initials: M
authors.lastname: Wang
authors.affiliation: c Mt Sinai Hospital , New York , NY , USA.
authors.forename: Sundar
authors.initials: S
authors.lastname: Jagannath
authors.affiliation: d Weill Cornell Medical College , New York , NY , USA.
authors.forename: Ruben
authors.initials: R
authors.lastname: Niesvizky
authors.affiliation: e University of Chicago Medical Center , Chicago , IL , USA.
authors.forename: Andrzej J
authors.initials: AJ
authors.lastname: Jakubowiak
authors.affiliation: f Onyx Pharmaceuticals, Inc., an Amgen subsidiary , South San Francisco , CA , USA.
authors.forename: Edward
authors.initials: E
authors.lastname: Kavalerchik
authors.affiliation: f Onyx Pharmaceuticals, Inc., an Amgen subsidiary , South San Francisco , CA , USA.
authors.forename: Mei
authors.initials: M
authors.lastname: Huang
authors.affiliation: g John Theurer Cancer Center at Hackensack University Medical Center , Hackensack , NJ , USA.
authors.forename: David S
authors.initials: DS
authors.lastname: Siegel
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D014408:Biomarkers, Tumor; D019008:Drug Resistance, Neoplasm; D006801:Humans; D007147:Immunoglobulin Light Chains / Q000097:blood*; D009101:Multiple Myeloma / Q000097:blood* / Q000188:drug therapy / Q000401:mortality* / Q000473:pathology; D009842:Oligopeptides / Q000494:pharmacology / Q000627:therapeutic use; D011379:Prognosis; D061988:Proteasome Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D012008:Recurrence; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D014408:Biomarkers, Tumor; D007147:Immunoglobulin Light Chains; D009842:Oligopeptides; D061988:Proteasome Inhibitors; C524865:carfilzomib